| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −1.6× | −1.7× | |
| Price / Book | 0.6× | 2.0× | |
| Price / Sales | 1.5× | 4.0× | |
| Price / Free cash flow | −6.1× | −1.5× | |
| EV / EBITDA | −1.8× | −1.2× | |
| Earnings yield | −61.6% | −14.3% | |
| Free cash flow yield | −16.3% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,285.05 | +3.60% | $1.21T | 56.6× | 77.8% | +15.2% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $258.80 | +1.97% | $623.68B | 22.8× | 32.9% | +32.1% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $287.88 | +1.84% | $508.72B | 118.2× | −129.2% | +24.6% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $419.53 | +3.11% | $376.57B | 30.3× | 12.8% | +14.1% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $148.03 | +3.06% | $365.22B | 19.4× | 34.7% | +71.2% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $153.49 | +2.19% | $282.96B | 19.7× | 30.5% | +14.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $168.72 | +2.91% | $261.67B | 24.8× | 21.1% | −2.4% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $688.14 | +1.29% | $254.44B | 37.3× | 12.6% | +26.6% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $436.06 | +2.62% | $235.75B | 29.8× | 89.1% | +43.7% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $156.07 | +1.96% | $193.52B | 22.3× | 37.5% | +29.9% |
